Modulation of metabolic activity of phagocytes by antihistamines

Interdisciplinary Toxicology

Volumn 4, Issue 1, 2011, Pages 15-19

  Lojek, Antonin ^a   ČíŽ, Milan ^a   Pekarová, Michaela ^a   Ambrožová, Gabriela ^a   Vašíček, Ondřej ^a   Moravcová, Jana ^a   Kubala, Lukáš ^a   Drábiková, Katarína ^b   Jančinová, Viera ^b   Perečko, Tomáš ^b   Pečivová, Jana ^b   MačIčková, Tatiana ^b   Nosál, Radomír ^b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

antihistamines; nitric oxide; oxidative burst; phagocytes; reactive oxygen species

Indexed keywords

ACRIVASTINE; ANTAZOLINE; ANTIHISTAMINIC AGENT; BROMPHENIRAMINE; CHLORCYCLIZINE; CHLORPHENIRAMINE; CLEMASTINE; CYCLIZINE; DITHIADEN; EMBRAMINE; HYDROXYL RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; KETOTIFEN; LIPOPOLYSACCHARIDE; LORATADINE; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FREE SYSTEM; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; FLUOROMETRY; INHIBITION KINETICS; MACROPHAGE; MALE; METABOLISM; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PROTEIN EXPRESSION; RAT; RESPIRATORY BURST; SPECTROPHOTOMETRY; WESTERN BLOTTING;

RATTUS;

EID: 79955117492     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-011-0004-z     Document Type: Article

References (14)

1. Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. (2001). Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gammaand G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. Mol Pharmacol 60: 1133-1142. (Pubitemid 33027449)
2. Church MK. (2001). H(1)-antihistamines and infl ammation. Clin Exp Allergy 31: 1341-1343.
3. Číž M, Čížová H, Denev P, Kratchanova M, Slavov A, Lojek A. (2010). Different methods for control and comparison of the antioxidant properties of vegetables. Food Control 21: 518-523.
4. Číž M, Komrsková D, Prachaøová L, Okénková K, Čížová H, Moravcová A, Janèinová V, Petríková M, Lojek A, Nosál' R. (2007). Serotonin modulates the oxidative burst of human phagocytes via various mechanisms. Platelets 18: 583-590.
5. De Vos C. (1999). H1-receptor antagonists: effects on leukocytes, myth or reality? Clin Exp Allergy 29: 60-63.
6. Drábiková K, Nosál' R, Janèinová V, Číž M, Lojek A. (2002). Reactive oxygen metabolites production is inhibited by histamine and H1-antagonist dithiaden in human PMN-leukocyte. Free Radical Res 36, 975-980. (Pubitemid 34863645)
7. Králová J., Raèková L, Pekarová M, Kubala L, Nosál' R, Janèinová V, Číž M, Lojek A. (2009). The effects of H1-antihistamines on the nitric oxide production by RAW 264.7 cells with respect to their lipophilicity. Int Immunopharmacol 9: 990-995.
8. Leurs R, Smit MJ, Timmerman H. (1995). Molecular pharmacological aspects of histamine receptors. Pharmacol Ther 66: 413-463.
9. Moncada S, Higgs A. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012. (Pubitemid 24015045)
10. Nosál' R, Janèinová V, Číž M, Drábiková K, Lojek A, Fábryová V. (2005). Inhibition of chemiluminescence by carvedilol in the cell-free system, whole human blood and blood cells. Scand J Clin Lab Invest 65, 55-64. (Pubitemid 40278312)
11. Pavelková M, Kubala L. (2004). Luminol-, isoluminol-and lucigenin-enhanced chemiluminescence of rat blood phagocytes stimulated with diff erent activators. Luminescence 19: 37-42. (Pubitemid 40341049)
12. Pekarová M, Králová J, Kubala L, Číž M, Lojek A, Gregor È, Hrbè J. (2009). Continuous electrochemical monitoring of nitric oxide production in murine macrophage cell line RAW 264.7. Anal Bioanal Chem 394: 1497-1504.
13. Tiligada E, Zampeli E, Sander K, Stark H. (2009). Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 18: 1519-1531.
14. Yang EJ, Yim EY, Song G, Kim GO, Hyun CG. (2009). Inhibition of nitric oxide production in lipopolysaccharide-activated RAW 264.7 macrophages by Jeju plant extracts. Interdiscip Toxicol 2: 245-249.